{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:15:29Z","timestamp":1771654529318,"version":"3.50.1"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Obesity can lead to chronic health complications such as nonalcoholic fatty liver disease (NAFLD). NAFLD is characterized by lipid aggregation in the hepatocytes and inflammation of the liver tissue as a consequence that can contribute to the development of cirrhosis and hepatocellular carcinoma (HCC). Previously, we reported that feeding obese Zucker rats with soy protein isolate (SPI) can reduce liver steatosis when compared with a casein (CAS) diet as a control. However, the effects of SPI on cytochrome P450 (CYP) in an obese rat model are less known. In addition, there is a lack of information concerning the consumption of soy protein in adolescents and its effect in reducing the early onset of NAFLD in this group. Our main goal was to understand if the SPI diet had any impact on the hepatic CYP gene expression when compared with the CAS diet. For this purpose, we used the transcriptomic data obtained in a previous study in which liver samples were collected from obese rats after short-term (eight-week) and long-term (16-week) feeding of SPI (<jats:italic>n<\/jats:italic> = 8 per group). To analyze this RNAseq data, we used Ingenuity Pathway Analysis (IPA) software. Comparing short- vs long-term feeding revealed an increase in the number of downregulated CYP genes from three at 8 weeks of SPI diet to five at 16 weeks of the same diet (<jats:italic>P<\/jats:italic> \u2264 0.05). On the other hand, upregulated CYP gene numbers showed a small increase in the long-term SPI diet compared to the short-term SPI diet, from 14 genes at 8 weeks to 17 genes at 16 weeks (<jats:italic>P<\/jats:italic> \u2264 0.05). The observed changes may have an important role in the attenuation of liver steatosis.<\/jats:p>","DOI":"10.3389\/fnut.2021.699620","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T05:06:36Z","timestamp":1624856796000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of Short- and Long-Term Soy Protein Feeding on Hepatic Cytochrome P450 Expression in Obese Nonalcoholic Fatty Liver Disease Rat Model"],"prefix":"10.3389","volume":"8","author":[{"given":"Melisa","family":"Kozaczek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Bottje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diyana","family":"Albataineh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Hakkak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat Rev Endocrinol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.metabol.2018.09.005","article-title":"The epidemiology of obesity","volume":"92","author":"Chooi","year":"2019","journal-title":"Metabolism."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/hep4.1534","article-title":"Mortality of NAFLD according to the body composition and presence of metabolic abnormalities","volume":"4","author":"Golabi","year":"2020","journal-title":"Hepatol Commun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol."},{"key":"B7","unstructured":"Prevalence of obesity among adults and youth: United States, 2015-201628818\n            HalesCM\n            CarrollMD\n            FryarCD\n            OgdenCL\n          29155689NCHS Data Brief.2017"},{"key":"B8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s11901-017-0378-2","article-title":"Natural history of NAFLD\/NASH","volume":"16","author":"Ekstedt","year":"2017","journal-title":"Curr Hepatol Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/hep4.1625","article-title":"The natural history of NAFLD, a community-based study at a large health care delivery system in the United States","volume":"5","author":"Nyberg","year":"2021","journal-title":"Hepatol Commun."},{"key":"B10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/biomedicines8070229","article-title":"Depression and cognitive impairment-Extrahepatic manifestations of NAFLD and NASH","volume":"8","author":"Colognesi","year":"2020","journal-title":"Biomedicines."},{"key":"B11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3109\/03602532.2011.577781","article-title":"Drug metabolism alterations in nonalcoholic fatty liver disease","volume":"43","author":"Merrell","year":"2011","journal-title":"Drug Metab Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cld.2016.08.001","article-title":"Drug metabolism in the liver","volume":"21","author":"Almazroo","year":"2017","journal-title":"Clin Liver Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2174\/1389450118666170125144557","article-title":"Cytochrome P450 structure, function and clinical significance: a review","volume":"19","author":"Manikandan","year":"2018","journal-title":"Curr Drug Targets."},{"key":"B14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tiv.2019.05.019","article-title":"Validation of in vitro methods for human cytochrome P450 enzyme induction: outcome of a multi-laboratory study","volume":"60","author":"Bernasconi","year":"2019","journal-title":"Toxicol In Vitro."},{"key":"B15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12045-014-0031-0","article-title":"Drug metabolism","volume":"19","author":"Taxak","year":"2014","journal-title":"Resonance."},{"key":"B16","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1124\/dmd.111.040592","article-title":"Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease","volume":"39","author":"Lake","year":"2011","journal-title":"Drug Metab Dispos."},{"key":"B18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/hep.1840210121","article-title":"Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease","volume":"21","author":"George","year":"1995","journal-title":"Hepatology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/004982599238704","article-title":"Effect of diet and nutrition on the expression of cytochromes P450","volume":"29","author":"Ioannides","year":"1999","journal-title":"Xenobiotica."},{"key":"B20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pharmthera.2010.01.009","article-title":"Dietary flavonoids in cancer therapy and prevention: substrates and inhibitors of cytochrome P450 CYP1 enzymes","volume":"126","author":"Androutsopoulos","year":"2010","journal-title":"Pharmacol Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3945\/jn.108.103572","article-title":"Human CYP3A4 and murine Cyp3A11 are regulated by equol and genistein via the pregnane X receptor in a species-specific manner","volume":"139","author":"Li","year":"2009","journal-title":"J Nutr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3390\/nu8120754","article-title":"Soy and health update: evaluation of the clinical and epidemiologic literature","volume":"8","author":"Messina","year":"2016","journal-title":"Nutrients."},{"key":"B23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/jn\/132.3.559S","article-title":"The health consequences of early soy consumption","volume":"132","author":"Badger","year":"2002","journal-title":"J Nutr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"26060","DOI":"10.1007\/s11356-019-05862-z","article-title":"Soybean isoflavone ameliorates cognitive impairment, neuroinflammation, and amyloid \u03b2 accumulation in a rat model of Alzheimer's disease","volume":"26","author":"Essawy","year":"2019","journal-title":"Environ Sci Pollut Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.nut.2018.06.025","article-title":"Ingestion of soy protein isolate attenuates eccentric contraction-induced force depression and muscle proteolysis via inhibition of calpain-1 activation in rat fast-twitch skeletal muscle","volume":"58","author":"Kanzaki","year":"2019","journal-title":"Nutrition."},{"key":"B26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.lfs.2016.06.014","article-title":"The effects of genistein supplementation on fructose induced insulin resistance, oxidative stress and inflammation","volume":"158","author":"Incir","year":"2016","journal-title":"Life Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/cdn\/nzz044.P08-033-19","article-title":"Effects of diet containing soy protein isolate on liver metabolic methylation status using obese Zucker rat model (P08-033-19)","volume":"3","author":"Hakkak","year":"2019","journal-title":"Curr Dev Nutr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/nutrit\/nux016","article-title":"Health impact of childhood and adolescent soy consumption","volume":"75","author":"Messina","year":"2017","journal-title":"Nutr Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1089\/jmf.2015.0002","article-title":"Short- and long-term soy diet versus casein protects liver steatosis independent of the arginine content","volume":"18","author":"Hakkak","year":"2015","journal-title":"J Med Food."},{"key":"B30","doi-asserted-by":"publisher","first-page":"607970","DOI":"10.3389\/fnut.2020.607970","article-title":"Long-term soy protein isolate consumption reduces liver steatosis through changes in global transcriptomics in obese Zucker rats","volume":"7","author":"Kozaczek","year":"2020","journal-title":"Front Nutr."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/jmf.2020.0180","article-title":"A Comparison of Short and Long-Term Soy Protein Isolate Intake and its ability to reduce Liver Steatosis in obese Zucker Rats through modifications of genes involved in inflammation and lipid transport","author":"Kozaczek","year":"2021","journal-title":"J Med Food."},{"key":"B32","doi-asserted-by":"publisher","first-page":"8218","DOI":"10.1039\/C9FO01387C","article-title":"Comparison of liver gene expression by RNAseq and PCR analysis after 8 weeks of feeding soy protein isolate- or casein-based diets in an obese liver steatosis rat model","volume":"10","author":"Kozaczek","year":"2019","journal-title":"Food Funct."},{"key":"B33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3892\/ol.2010.202","article-title":"Effects of high-isoflavone soy diet vs. casein protein diet and obesity on DMBA-induced mammary tumor development","volume":"2","author":"Hakkak","year":"2011","journal-title":"Oncol Lett"},{"key":"B34","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in Ingenuity Pathway Analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics."},{"key":"B35","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s12263-012-0294-6","article-title":"Dietary soy protein induces hepatic lipogenic enzyme gene expression while suppressing hepatosteatosis in obese female Zucker rats bearing DMBA-initiated mammary tumors","volume":"7","author":"Hakkak","year":"2012","journal-title":"Genes Nutr."},{"key":"B36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/biomedicines6020055","article-title":"Short-term soy protein isolate feeding prevents liver steatosis and reduces serum ALT and AST levels in obese female zucker rats","volume":"6","author":"Hakkak","year":"2018","journal-title":"Biomedicines."},{"key":"B37","article-title":"Liver Transcriptomic Analysis After Short- and Long-term Feeding of Soy Protein Isolate and Its Ability to Reduce Liver Steatosis in Obese Zucker Rats (PhD Dissertation)","author":"Kozaczek","year":"2020"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","article-title":"Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From \u201ctwo hit theory\u201d to \u201cmultiple hit model.\u201d","volume":"24","author":"Fang","year":"2018","journal-title":"World J Gastroenterol"},{"key":"B39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-3-319-95828-6_7","article-title":"The natural history of NAFLD: environmental vs. genetic risk factors","volume-title":"Non-Alcoholic Fatty Liver Disease","author":"Valenti","year":"2020"},{"key":"B40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.prostaglandins.2016.07.002","article-title":"Characterization of the Cytochrome P450 epoxyeicosanoid pathway in non-alcoholic steatohepatitis","volume":"125","author":"Wells","year":"2016","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"B41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00204-020-02939-4","article-title":"Cross-species analysis of hepatic cytochrome P450 and transport protein expression","volume":"95","author":"Hammer","year":"2021","journal-title":"Arch Toxicol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e7429","DOI":"10.7717\/peerj.7429","article-title":"Age-associated changes of cytochrome P450 and related phase-2 gene\/proteins in livers of rats","volume":"2019","author":"Xu","year":"2019","journal-title":"PeerJ."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(02)11203-7","article-title":"Clinical importance of the cytochromes P450","volume":"360","author":"Nebert","year":"2002","journal-title":"Lancet."},{"key":"B44","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s10562-017-2273-4","article-title":"Regioselective biocatalytic hydroxylation of fatty acids by cytochrome P450s","volume":"148","author":"Hammerer","year":"2018","journal-title":"Catal Lett."},{"key":"B45","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1194\/jlr.M700450-JLR200","article-title":"Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11","volume":"49","author":"Dhar","year":"2008","journal-title":"J Lipid Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2009\/952734","article-title":"PPAR\/RXR Regulation of fatty acid metabolism and fatty acid \u03c9-hydroxylase (CYP4) isozymes: implications for prevention of lipotoxicity in fatty liver disease","volume":"2009","author":"Hardwick","year":"2009","journal-title":"PPAR Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1124\/dmd.109.027466","article-title":"Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease","volume":"37","author":"Fisher","year":"2009","journal-title":"Drug Metab Dispos."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.22034\/APJCP.2018.19.8.2057","article-title":"Cytochrome P450: polymorphisms and roles in cancer, diabetes and atherosclerosis","volume":"19","author":"Elfaki","year":"2018","journal-title":"Asian Pacific J Cancer Prev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e0153863","DOI":"10.1371\/journal.pone.0153863","article-title":"Cytochrome P4501A2 metabolizes 17\u03b2-estradiol to suppress hepatocellular carcinoma","volume":"11","author":"Ren","year":"2016","journal-title":"PLoS One."},{"key":"B50","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.etap.2016.05.014","article-title":"Impact of high-fat diet on liver genes expression profiles in mice model of nonalcoholic fatty liver disease","volume":"45","author":"Wang","year":"2016","journal-title":"Environ Toxicol Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1002\/jcph.1483","article-title":"Ontogeny of phase I metabolism of drugs","volume":"59","author":"Allegaert","year":"2019","journal-title":"J Clin Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.tiv.2006.07.008","article-title":"Effects of steatosis on drug-metabolizing capability of primary human hepatocytes","volume":"21","author":"Donato","year":"2007","journal-title":"Toxicol In Vitro."},{"key":"B53","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/138920011794520035","article-title":"Does hepatic steatosis affect drug metabolizing enzymes in the liver?","volume":"12","author":"Buechler","year":"2011","journal-title":"Curr Drug Metab."},{"key":"B54","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.bbalip.2014.07.020","article-title":"Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism","volume":"1851","author":"Spector","year":"2015","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids."},{"key":"B55","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.pharmthera.2014.05.011","article-title":"Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders","volume":"144","author":"Shahabi","year":"2014","journal-title":"Pharmacol Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fgene.2013.00002","article-title":"Molecular interactions between NAFLD and xenobiotic metabolism","volume":"4","author":"Naik","year":"2013","journal-title":"Front Genet."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/j.1440-1746.2009.06196.x","article-title":"Oxidative stress and regulation of anti-oxidant enzymes in cytochrome P4502E1 transgenic mouse model of non-alcoholic fatty liver","volume":"25","author":"Kathirvel","year":"2010","journal-title":"J Gastroenterol Hepatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/hep4.1115","article-title":"The role of human cytochrome P450 2E1 in liver inflammation and fibrosis","volume":"1","author":"Xu","year":"2017","journal-title":"Hepatol Commun."},{"key":"B59","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/03602532.2016.1206562","article-title":"Effects of soy containing diet and isoflavones on cytochrome P450 enzyme expression and activity","volume":"48","author":"Ronis","year":"2016","journal-title":"Drug Metab Rev."},{"key":"B60","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/03602530701468573","article-title":"Human cytochrome P450 family 4 enzymes: function, genetic variation and regulation","volume":"39","author":"Hsu","year":"2008","journal-title":"Drug Metab Rev."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.bcp.2008.03.004","article-title":"Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases","volume":"75","author":"Hardwick","year":"2008","journal-title":"Biochem Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1073\/pnas.1700172114","article-title":"Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis","volume":"114","author":"Zhang","year":"2017","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B63","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cotox.2017.02.004","article-title":"The aryl hydrocarbon receptor repressor - More than a simple feedback inhibitor of AhR signaling: clues for its role in inflammation and cancer","volume":"1","author":"Vogel","year":"2017","journal-title":"Curr Opin Toxicol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cotox.2017.01.001","article-title":"Canonical and non-canonical aryl hydrocarbon receptor signaling pathways","volume":"2","author":"Wright","year":"2017","journal-title":"Curr Opin Toxicol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/bcpt.13004","article-title":"Cytochrome P450 induction and xeno-sensing receptors pregnane X receptor, constitutive androstane receptor, aryl hydrocarbon receptor and peroxisome proliferator-activated receptor \u03b1 at the crossroads of toxicokinetics and toxicodynamics","volume":"123","author":"Hakkola","year":"2018","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1271\/bbb.90438","article-title":"The inhibitory mechanisms of the tyrosine kinase inhibitors herbimycin A, genistein, and tyrphostin B48 with regard to the function of the aryl hydrocarbon receptor in caco-2 cells","volume":"74","author":"Kasai","year":"2010","journal-title":"Biosci Biotechnol Biochem."},{"key":"B67","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.nutres.2016.01.001","article-title":"Genistein decreases basal hepatic cytochrome P450 1A1 protein expression and activity in Swiss Webster mice","volume":"36","author":"Froyen","year":"2016","journal-title":"Nutr Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/10408444.2019.1635987","article-title":"Dietary natural flavonoids treating cancer by targeting aryl hydrocarbon receptor","volume":"49","author":"Yang","year":"2019","journal-title":"Crit Rev Toxicol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.3390\/nu11112559","article-title":"Epigenetic activation of BRCA1 by genistein in vivo and triple negative breast cancer cells linked to antagonism toward aryl hydrocarbon receptor","volume":"11","author":"Donovan","year":"2019","journal-title":"Nutrients."},{"key":"B70","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.fct.2018.01.029","article-title":"Cytochrome P450 1A1 (CYP1A1) protects against nonalcoholic fatty liver disease caused by Western diet containing benzo [a] pyrene in mice","volume":"113","author":"Uno","year":"2017","journal-title":"Food Chem Toxicol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/toxsci\/kfy075","article-title":"Structure-dependent modulation of aryl hydrocarbon receptor-mediated activities by flavonoids","volume":"164","author":"Jin","year":"2018","journal-title":"Toxicol Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00008571-200401000-00001","article-title":"Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants","volume":"450","author":"Nelson","year":"2004","journal-title":"Pharmacogenetics."},{"key":"B73","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2174\/187231211794455280","article-title":"Comparative pharmacokinetics and metabolism studies in lean and diet- induced obese mice: an animal efficacy model for 11\u03b2-hydroxysteroid dehydrogenase type 1 (11\u03b2-HSD1) inhibitors","volume":"5","author":"Wang","year":"2011","journal-title":"Drug Metab Lett."},{"key":"B74","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.molmed.2018.03.005","article-title":"IL-1 family cytokine pathways underlying NAFLD: towards new treatment strategies","volume":"24","author":"Mirea","year":"2018","journal-title":"Trends Mol Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1096\/fj.02-0195fje","article-title":"Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: molecular mechanism and transcription factors involved","volume":"16","author":"Jover","year":"2002","journal-title":"FASEB J."},{"key":"B76","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/clpt.1994.150","article-title":"Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity","volume":"56","author":"O'Shea","year":"1994","journal-title":"Clin Pharmacol Ther."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1124\/dmd.115.065979","article-title":"CYP3A activity and expression in nonalcoholic fatty liver disease","volume":"43","author":"Woolsey","year":"2015","journal-title":"Drug Metab Dispos."},{"key":"B78","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/pharmaceutics9040040","article-title":"Tissue specific modulation of cyp2c and cyp3a mRNA levels and activities by diet-induced obesity in mice: the impact of type 2 diabetes on drug metabolizing enzymes in liver and extra-hepatic tissues","volume":"9","author":"Maximos","year":"2017","journal-title":"Pharmaceutics."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2021.699620\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T05:06:43Z","timestamp":1624856803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2021.699620\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,28]]},"references-count":78,"alternative-id":["10.3389\/fnut.2021.699620"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2021.699620","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,28]]},"article-number":"699620"}}